Daily Protocol: 1 to 2 mg subcutaneous injection once daily Alternate Protocol: 2 to 3 mg subcutaneous injection three times weekly Cycle Length: 8 to 12 weeks on Rest Period: 4 to 6 weeks off between cycles Cycles Per Year: 2 to 3 cycles recommended Injection Sites: Abdomen, outer thigh, or upper arm with rotation Cycling Recommendations Research suggests running GHK-Cu in cycles of 8 to 12 weeks followed by rest periods of 4 to 6 weeks
it shifts gene expression patterns toward a younger, healthier state
Similarly, MA inhibited M1 microglial polarization by modulating the RhoA/ROCK2 signaling pathway (Zhu et al., 2020)
Future studies are necessary to validate DEC in diverse populations and assess its impact on secondary glycation markers to confirm its broad-spectrum antiglycation capacity and potential for wider dermatological applications
Genetic analysis can guide treatment decisions, minimizing side effects
However, hCG also functions much like LH does in the body